{
    "id": 26498,
    "fullName": "AXIN1 V835fs",
    "impact": "frameshift",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "AXIN1 V835fs results in a change in the amino acid sequence of the Axin1 protein beginning at aa 835 of 862, likely resulting in premature truncation of the functional protein (UniProt.org). E835fs is associated with loss of Axin1 protein expression in combination with AXIN1 G265fs in culture (PMID: 28100566), but has not been characterized individually and therefore, its effect on Axin1 protein function is unknown (PubMed, Feb 2020).",
            "references": [
                {
                    "id": 8748,
                    "pubMedId": 28100566,
                    "title": "Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28100566"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 8312,
        "geneSymbol": "AXIN1",
        "terms": [
            "AXIN1",
            "AXIN",
            "PPP1R49"
        ]
    },
    "variant": "V835fs",
    "createDate": "04/28/2017",
    "updateDate": "02/20/2020",
    "referenceTranscriptCoordinates": {
        "id": 166721,
        "transcript": "NM_003502",
        "gDna": "chr16:g.(288208_288209)",
        "cDna": "c.(2503_2502)",
        "protein": "p.V835fs",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10767,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, AXIN1 frameshift mutations G265fs and V835fs resulted in reduced Axin1 protein expression, and confered resistance to LGK974 in colorectal cancer cells harboring PTPRK-RSPO3 in culture (PMID: 28100566).",
            "molecularProfile": {
                "id": 27772,
                "profileName": "PTPRK - RSPO3 AXIN1 G265fs AXIN1 V835fs"
            },
            "therapy": {
                "id": 1937,
                "therapyName": "LGK974",
                "synonyms": null
            },
            "indication": {
                "id": 9256,
                "name": "colorectal cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 8748,
                    "pubMedId": 28100566,
                    "title": "Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28100566"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27735,
            "profileName": "AXIN1 V835fs",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27772,
            "profileName": "PTPRK - RSPO3 AXIN1 G265fs AXIN1 V835fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 166721,
            "transcript": "NM_003502",
            "gDna": "chr16:g.(288208_288209)",
            "cDna": "c.(2503_2502)",
            "protein": "p.V835fs",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}